JiangXi Tianxin Pharmaceutical Co (603235) Fair Value & Analysis
Consumer Defensive · CN · Market cap 10.3B CNY
Fair value as of: Jun 24, 2026
Analysis
JiangXi Tianxin Pharmaceutical Co (603235) currently trades at ¥22.87, while our model-based Fair Value estimate is ¥18.70 — implying the stock looks roughly 18.2% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is JiangXi Tianxin Pharmaceutical Co (603235) undervalued?
What is the fair value of 603235?
What is the quality score of 603235?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.